David Meads

A Belgian consensus on the definition of a treat‐to‐target outcome set in psoriasis management

Endogenous Testosterone and Mortality in Men: A Systematic Review and Meta-Analysis

Haemodynamic definitions and updated clinical classification of pulmonary hypertension

Interleukin-6 and Tumor Necrosis Factor-α Are Associated with Quality of Life–Related Symptoms in Pulmonary Arterial Hypertension

Tadalafil Therapy for Pulmonary Arterial Hypertension

Testosterone therapy and cardiovascular events among men: a systematic review and meta-analysis of placebo-controlled randomized trials

CONSORT 2010 statement: extension to randomised pilot and feasibility trials

Testosterone Therapy in Men with Androgen Deficiency Syndromes: An Endocrine Society Clinical Practice Guideline

The Dermatology Life Quality Index 1994-2007: a comprehensive review of validation data and clinical results

Self-report fatigue questionnaires in multiple sclerosis, Parkinson’s disease and stroke: a systematic review of measurement properties

Quality of life of psoriatic patients evaluated by a new psychometric assessment tool: PsoDisk

Cardiovascular risk associated with testosterone-boosting medications: a systematic review and meta-analysis

Atopic dermatitis

Definitions and Diagnosis of Pulmonary Hypertension

Atopic Dermatitis: Global Epidemiology and Risk Factors

Adverse Effects of Testosterone Therapy in Adult Men: A Systematic Review and Meta-Analysis

Statistical tests, P values, confidence intervals, and power: a guide to misinterpretations

Updated Clinical Classification of Pulmonary Hypertension

Obesity and inflammation: the linking mechanism and the complications

Psoriasis

Evaluation of the structure of Brazilian State-Trait Anxiety Inventory using a Rasch psychometric approach

Conspiracy theory and cognitive style: a worldview

From Translation to Version Management: A History and Review of Methods for the Cultural Adaptation of the EuroQol Five-Dimensional Questionnaire

Changes in causes of death in systemic sclerosis, 1972–2002

Oral testosterone replacement in symptomatic late-onset hypogonadism: effects on rating scales and general safety in a randomized, placebo-controlled study

Clinical management of psoriatic arthritis

COSMIN guideline for systematic reviews of patient-reported outcome measures

Filaggrin loss-of-function mutations are associated with early-onset eczema, eczema severity and transepidermal water loss at 3 months of age

Updated Clinical Classification of Pulmonary Hypertension

Measures of systemic sclerosis (scleroderma): Health Assessment Questionnaire (HAQ) and Scleroderma HAQ (SHAQ), Physician‐ and Patient‐Rated Global Assessments, Symptom Burden Index (SBI), University of California, Los Angeles, Scleroderma Clinical Trials Consortium Gastrointestinal Scale (UCLA SCTC GIT) 2.0, Baseline Dyspnea Index (BDI) and Transition Dyspnea Index (TDI) (Mahler's Index), Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR), and Raynaud's Condition Score (RCS)

A new framework for developing and evaluating complex interventions: update of Medical Research Council guidance

Effects of Iron Supplementation and Depletion on Hypoxic Pulmonary Hypertension

Testosterone Induces Erythrocytosis via Increased Erythropoietin and Suppressed Hepcidin: Evidence for a New Erythropoietin/Hemoglobin Set Point

Long-term Use of Sildenafil in Inoperable Chronic Thromboembolic Pulmonary Hypertension

Hidradenitis suppurativa

Ulcerative colitis

Quality of life and childhood atopic dermatitis: the misery of living with childhood eczema

Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial

Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension

Sildenafil Improves Health-Related Quality of Life in Patients With Pulmonary Arterial Hypertension*

Critical Review of Generic and Dermatology-Specific Health-Related Quality of Life Instruments

The increase in pulmonary arterial pressure caused by hypoxia depends on iron status

Burn injury

The Evolution of Quality of Life Assessment and Use in Dermatology

Outcome of pulmonary endarterectomy in symptomatic chronic thromboembolic disease

Secukinumab in Plaque Psoriasis — Results of Two Phase 3 Trials

Brief Report: Effect of ambrisentan treatment on exercise‐induced pulmonary hypertension in systemic sclerosis: A prospective single‐center, open‐label pilot study

A cross-sectional study of the prevalence and associations of iron deficiency in a cohort of patients with chronic obstructive pulmonary disease

Nintedanib for Systemic Sclerosis–Associated Interstitial Lung Disease

Is the haematopoietic effect of testosterone mediated by erythropoietin? The results of a clinical trial in older men

Measures of anxiety: State‐Trait Anxiety Inventory (STAI), Beck Anxiety Inventory (BAI), and Hospital Anxiety and Depression Scale‐Anxiety (HADS‐A)

The Psoriasis Symptom Diary: development and content validity of a novel patient‐reported outcome instrument

The Development and Validation of the CARe Burn Scale—Adult Form: A Patient-Reported Outcome Measure (PROM) to Assess Quality of Life for Adults Living with a Burn Injury

Pulmonary Arterial Hypertension

Supplementation of Iron in Pulmonary Hypertension: Rationale and Design of a Phase II Clinical Trial in Idiopathic Pulmonary Arterial Hypertension

Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension

Mechanochemical ablation for the treatment of superficial venous incompetence: A cohort study of a single centre’s early experience

Understanding Conspiracy Theories

Adverse Health Consequences of Performance-Enhancing Drugs: An Endocrine Society Scientific Statement

Fuzzy Rasch model in TOPSIS: A new approach for generating fuzzy numbers to assess the competitiveness of the tourism industries in Asian countries

Fuzzy multiple criteria decision-making techniques and applications – Two decades review from 1994 to 2014

ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension

A state-of the-art survey of TOPSIS applications

Industry sponsorship and research outcome

Lifestyle referral assessment in an acute cardiology setting: study protocol for a randomized controlled feasibility trial

Development and validation of a preference based measure derived from the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) for use in cost utility analyses

Effects of Method of Translation of Patient-Reported Health Outcome Questionnaires: A Randomized Study of the Translation of the Rheumatoid Arthritis Quality of Life (RAQoL) Instrument for Sweden

Quality of life in infants and children with atopic dermatitis: Addressing issues of differential item functioning across countries in multinational clinical trials

The Quality of Life of Parents of Children with Atopic Dermatitis: Interpretation of PIQoL-AD Scores

The responsiveness and validity of the CAMPHOR Utility Index

Adaptation of the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) into French‐Canadian and English‐Canadian

A Randomized Feasibility Trial of a New Lifestyle Referral Assessment Versus Usual Assessment in an Acute Cardiology Setting

Cross-Cultural Inequivalence of Dermatology-Specific Health-Related Quality of Life Instruments in Psoriasis Patients

Requirements for Quality of Life Instruments in Clinical Research

United States Validation of the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR)

Double‐blind placebo‐controlled study of testosterone patch therapy on bone turnover in men with borderline hypogonadism

Effect of tight control of inflammation in early psoriatic arthritis (TICOPA): a UK multicentre, open-label, randomised controlled trial

International Development of the Unidimensional Fatigue Impact Scale (U-FIS)

Can We Rely on the Dermatology Life Quality Index as a Measure of the Impact of Psoriasis or Atopic Dermatitis?

The Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR): A Measure of Health-Related Quality of Life and Quality of Life for Patients with Pulmonary Hypertension

Functionality and feedback: a realist synthesis of the collation, interpretation and utilisation of patient-reported outcome measures data to improve patient care

In a dark time: Development, validation, and correlates of the Durham hypnagogic and hypnopompic hallucinations questionnaire

Rasch analysis and item reduction of the hypomanic personality scale